Drug Interactions in Substance Abusers with HIV Infection and Other Comorbid Conditions (R01)

The summary for the Drug Interactions in Substance Abusers with HIV Infection and Other Comorbid Conditions (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Drug Interactions in Substance Abusers with HIV Infection and Other Comorbid Conditions (R01): This funding opportunity announcement (FOA) solicits grant applications through the NIH Investigator initiated Research Grant (R01) award mechanism from applicant organizations to gain new knowledge on the subject of drug-drug interactions observed during the treatment of infections in drug addicts.
Federal Grant Title: Drug Interactions in Substance Abusers with HIV Infection and Other Comorbid Conditions (R01)
Federal Agency Name: National Institutes of Health
Grant Categories: Health Education
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-DA-08-011
Type of Funding: Grant
CFDA Numbers: 93.279
CFDA Descriptions: Drug Abuse and Addiction Research Programs
Current Application Deadline: No deadline provided
Original Application Deadline: Feb 28, 2008
Posted Date: Nov 27, 2007
Creation Date: Nov 27, 2007
Archive Date: Mar 30, 2008
Total Program Funding: $1,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Native American tribal organizations (other than Federally recognized tribal governments) Special district governments State governments Native American tribal governments (Federally recognized) Private institutions of higher education For profit organizations other than small businesses Public and State controlled institutions of higher education Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts County governments Others (see text field entitled "Additional Information on Eligibility" for clarification) Public housing authorities/Indian housing authorities City or township governments
Additional Information on Eligibility
Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Coordination, An...
Targeting Inflammasomes in Substance Abuse and HIV (R01 Clinical Trial Not Allowed)
Research Networks for the Study of Recovery Support Services for Persons Treated with Medi...
The Rat Opioid Genome Project: Clinical Trials not Allowed (U01- Clinical Trial Not Allowe...
The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Required)
NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
Drug Abuse Aspects of Hiv/Aids and Other Infections
Epidemiology of Drug Abuse
More Grants from the National Institutes of Health
Accelerating Discovery of Efficacious Pre-erythrocytic Stage Malaria Vaccines (U01 Clinica...
Understanding Phage Biology to Support the Development of Bacteriophage Therapy (R21 Clini...
Strategies to Improve Health Outcomes and to Reduce Disparities in Rural Populations (R01 ...
Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01 Clinical T...
Organotypic Culture Models developed from Experimental Animals for Chemical Toxicity Scree...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2019 FederalGrants.com